France launches breast and ovarian cancer study:
This article was originally published in Clinica
A new study has been launched in France to monitor patients at risk of familial cancer. The study, established by the cancer and genetics group of the national anticancer federation, will monitor women who have a family history of breast and ovarian cancer. The group estimates that this represents some 5-10% of female cancer cases, who have on average a 50% chance of developing cancer by the age of 50 (2% of the general population). Almost 1,000 women will be monitored for two years.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.